Fecal occult blood testing completion in a VA population: Low and strongly related to race

Journal of Clinical Outcomes Management

Volumn 14, Issue 2, 2007, Pages 93-98

  Fisher, Deborah A ^a,d   Johnson, Marcus R ^b   Shaheen, Nicholas J ^c  

^a DURHAM VA MEDICAL CENTER   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER SCREENING; CAUCASIAN; COLORECTAL CANCER; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DEMOGRAPHY; EUROPEAN AMERICAN; FEMALE; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OCCULT BLOOD; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; RACE DIFFERENCE; RETROSPECTIVE STUDY; RURAL POPULATION; STATISTICAL SIGNIFICANCE; URBAN POPULATION; VETERAN;

EID: 33947202649     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Screening for colorectal cancer: recommendation and rationale. U.S. Preventive Services Task Force. Ann Intern Med 2002; 137:129-31.
2. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastrointestinal Consortium Panel. Gastroenterology 2003;124:544-60.
3. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study [published erratum appears in N Engl J Med 1993;329:672]. N Engl J Med 1993;328:1363-71.
4. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
5. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
6. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997;89:1406-22.
7. Greiner KA, James AS, Born W, et al. Predictors of fecal occult blood test (FOBT) completion among low-income adults. Prev Med 2005;41:676-84.
8. Colorectal cancer test use among persons aged > or = 50 years-United States, 2001. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2003;52:193-6.
9. El-Serag HB, Petersen L, Hampel H, et al. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med 2006;166:2202-8.
10. U.S. Dept. of Veterans Affairs. Chronic disease index and prevention index report [unpublished annual report]. Washington (DC): Dept. of Veterans Affairs; 1996.
11. VA intranet. Available at www.nchpdp.med.va.gov/2005_ PerfMeasPrevServ.asp. Accessed 14 Apr 2005.
12. Kashner TM. Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care 1998;36:1324-36.
13. Ko CW, Dominitz, JA, Nguyen TD. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am J Med 2003;115:111-4.
14. Stokamer CL, Tenner CT, Chaudhuri J, et al. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med 2005;20:278-82.
15. U.S. Census Bureau. Current lists of metropolitan and micropolitan statistical areas and definitions. Available at www. census.gov/population/www/ estimates/metrodef.html. Accessed 17 Jan 2007.
16. Zip-Codes.com. Zip code database definitions of geographic concepts, including maps. Available at www.zip-codes.com/ zip_code_definitions.asp. Accessed 18 Jan 2007.
17. Fisher DA, Judd L, Sanford NS. Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol 2005;100:2526-30.
18. Heisler M, Smith DM, Hayward RA, et al. Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care 2003;41:1221-32.
19. Freeman VL, Durazo-Arvizu R, Arozullah AM, Keys LC. Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems. Am J Public Health 2003;93:1706-12.
20. Dolan NC, Ferreira MR, Fitzgibbon ML, et al. Colorectal cancer screening among African-American and white male veterans. Am J Prev Med 2005;28:479-82.
21. National Quality Measures Clearinghouse. Colon cancer: percent of patients receiving timely colorectal cancer screening (NEXUS clinics cohort). Agency for Healthcare Research and Quality. Available at www.qualitymeasures. ahrq.gov/ summary/summary.aspx?doc_id=5083. Accessed 17 Jan 2007.
22. James AS, Campbell MK, Hudson MA. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomarkers Prev 2002;11:529-34.
23. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med 2005;165:2129-35.